Related Experiment Video
Updated: Jul 8, 2026

Receptor Autoradiography Protocol for the Localized Visualization of Angiotensin II Receptors
Published on: June 7, 2016
Brain angiotensin receptors and binding proteins
Robert C Speth1, Vardan T Karamyan
1Department of Pharmacology, Research Institute of Pharmaceutical Sciences, University of Mississippi, University, Oxford, MS 38677, USA. Speth@Olemiss.edu
The brain has AT1 and AT2 receptors for angiotensin II (Ang II), a peptide hormone. A novel brain-specific binding site for Ang II, distinct from AT1/AT2 receptors, has been discovered.
Area of Science:
- Neuroscience
- Endocrinology
- Biochemistry
Background:
- The brain angiotensin system involves angiotensin II (Ang II) and its AT1 and AT2 receptors, which are G protein-coupled receptors (GPCRs).
- Research is uncovering new signal transduction pathways and protein interactions for Ang II receptors.
- A controversy exists regarding the specific active angiotensin peptide acting on brain AT1 receptors.
Purpose of the Study:
- To review classical and novel aspects of the brain angiotensin system.
- To address the controversy surrounding the active angiotensin peptide for brain AT1 receptors.
- To summarize the discovery and characteristics of a novel, brain-specific angiotensin peptide binding site.
Main Methods:
- Literature review of classical and novel findings on the brain angiotensin system.
- Discussion of established knowledge on AT1 and AT2 receptor subtypes.
- Summary of recent research on a novel angiotensin binding site, including its properties and potential activators.
Main Results:
- The brain expresses both AT1 and AT2 angiotensin II receptors, which are GPCRs.
- A novel, brain-specific, membrane-bound binding site for angiotensin peptides, independent of AT1 and AT2 receptors, has been identified.
- This novel site is unmasked by p-chloromercuribenzoic acid (PCMB) within a specific concentration range, suggesting dependence on the brain's redox state.
Conclusions:
- The brain angiotensin system is complex, involving known receptors and a newly discovered binding site.
- The novel binding site's characteristics and its dependence on brain redox state warrant further investigation.
- This site may mediate non-traditional actions of Ang II in the brain, such as dopamine release, or function as a peptidase or clearance receptor.
Related Concept Videos
Antihypertensive Drugs: Angiotensin II Receptor Blockers
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
Antihypertensive Drugs: Direct Renin Inhibitors
Antihypertensive Drugs: Action of β1 Blockers
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
